If you have forgotten your password, please enter your email address below and click "Reset Password". A new password will be assigned to your account and emailed to you.
https://www.smithers.com/resources/2026/march/antidrug-antibody-testing-in-immuno-oncology
At Smithers Pharmaceutical Development Services, qPCR and ddPCR are not viewed as competing technologies, but as complementary tools. The real question is not “which is newer,” but “which platform best answers the scientific and regulatory question at hand.”
Smithers presents on overcoming matrix interference in ADA assays at the Immunogenicity & Bioassay Summit. Learn about our advanced immunogenicity testing.
Smithers delivers the bioanalytical expertise required to build, validate, and scale biomarker programs for large molecule therapeutics. Sponsors seeking to strengthen clinical outcomes, reduce development risk, and align with evolving regulatory expectations should engage with Smithers to define a biomarker strategy tailored to their program.
The future of drug development is increasingly virtual, and consultant driven. Smithers Pharmaceutical Development Services has intentionally designed its style of scientific engagement to support this reality. Their model gives growing companies what they need most: clarity, predictability, and a partner who understands the pressures and constraints of early-stage development.
Optimized NAb Assay Strategies for Bi-Specific Therapeutics
As the industry gathers in San Diego for SOT 2026, Smithers Pharmaceutical Development Services will be taking the stage to address one of the most pressing and practical topics in modern preclinical development: how to effectively integrate molecular platforms into regulated toxicology studies.
Smithers molecular biology services integrate seamlessly into your development pipeline—bringing clarity, consistency, and confidence to every stage.
Download our whitepaper for harmonized recommendations on reporting clinical anti-drug antibody (ADA) assay results to facilitate agency filings.
Download our expert-developed white paper for practical insights and an editable template to streamline your neutralizing antibody sample analysis reporting process.
Our site uses cookies so that we can remember you and understand how you use our site. You can read more about cookies and similar technologies here. Otherwise, you agree to the use of the cookies as they are currently set.
